| Sanford Roy Hoffman, MD | |
|
14510 W Shumway Dr Ste 101, Sun City West, AZ 85375-5815 | |
| (623) 975-1660 | |
| (623) 584-4282 |
| Full Name | Sanford Roy Hoffman |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 59 Years |
| Location | 14510 W Shumway Dr Ste 101, Sun City West, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063440444 | NPI | - | NPPES |
| 040016859 | Other | AZ | RRB |
| 020539454 | Other | AZ | HUMANA |
| 020539454 | Other | AZ | DEPT OF LABOR-FECA |
| 020539454 | Other | AZ | SUN HEALTH CORPORATION |
| 1063440444 | Other | AZ | BCBS |
| 020539454 | Other | AZ | UNITED HEALTHCARE |
| 020539454 | Other | AZ | SECURE HORIZONS |
| 020539454 | Other | AZ | PACIFICARE |
| 020539454 | Other | AZ | BLUE CROSS BLUE SHIELD |
| 818932 | Other | AZ | AHCCCS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 31846 (Arizona) | Secondary |
| 174400000X | Specialist | 31846 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arizona Ear Nose And Throat Physicians Pllc | 5698758357 | 2 |
News Archive
Varying practices and frequent lapses in nutrition delivery can put critically ill patients at greater risk for malnutrition and associated complications, according to an article in the August issue of Critical Care Nurse (CCN).
Two prominent microbiologists have launched a new peer-reviewed publication focusing on microbiome research in environmental, agricultural, and biomedical areas. Eric Wommack, from the University of Delaware's College of Earth, Ocean and Environment and Jacques Ravel, from the University of Maryland School of Medicine's Institute for Genome Sciences are the Editors-in-Chief of Microbiome, a BioMed Central (BMC) publication, which launched its first issue this week.
A new study led by researchers at Indiana University has found that women and older adults who use multiple prescription drugs are significantly more likely to be prescribed pills whose combination produces dangerous side effects.
Informed Medical Decisions, Inc. (InformedDNA) has been selected as one of 30 finalists for the Best Practices in Health Care Consumer Empowerment and Protection Awards. URAC, the nation's leading accreditation organization, will honor the finalists during their 11th Annual Quality Summit, October 5-7, 2010 in Chicago, IL.
Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping mutation had a 46.5% objective response rate to the targeted therapy drug tepotinib, as shown in a study published today in the New England Journal of Medicine and presented at the 2020 American Society of Clinical Oncology Annual Meeting ASCO20 Virtual Meeting (Abstract 9556 - Poster 322) by researchers from The University of Texas MD Anderson Cancer Center.
› Verified 7 days ago
| Entity Name | Arizona Ear Nose And Throat Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730365958 PECOS PAC ID: 5698758357 Enrollment ID: O20040611001351 |
News Archive
Varying practices and frequent lapses in nutrition delivery can put critically ill patients at greater risk for malnutrition and associated complications, according to an article in the August issue of Critical Care Nurse (CCN).
Two prominent microbiologists have launched a new peer-reviewed publication focusing on microbiome research in environmental, agricultural, and biomedical areas. Eric Wommack, from the University of Delaware's College of Earth, Ocean and Environment and Jacques Ravel, from the University of Maryland School of Medicine's Institute for Genome Sciences are the Editors-in-Chief of Microbiome, a BioMed Central (BMC) publication, which launched its first issue this week.
A new study led by researchers at Indiana University has found that women and older adults who use multiple prescription drugs are significantly more likely to be prescribed pills whose combination produces dangerous side effects.
Informed Medical Decisions, Inc. (InformedDNA) has been selected as one of 30 finalists for the Best Practices in Health Care Consumer Empowerment and Protection Awards. URAC, the nation's leading accreditation organization, will honor the finalists during their 11th Annual Quality Summit, October 5-7, 2010 in Chicago, IL.
Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping mutation had a 46.5% objective response rate to the targeted therapy drug tepotinib, as shown in a study published today in the New England Journal of Medicine and presented at the 2020 American Society of Clinical Oncology Annual Meeting ASCO20 Virtual Meeting (Abstract 9556 - Poster 322) by researchers from The University of Texas MD Anderson Cancer Center.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sanford Roy Hoffman, MD 14510 W Shumway Dr Ste 101, Sun City West, AZ 85375-5815 Ph: (623) 975-1660 | Sanford Roy Hoffman, MD 14510 W Shumway Dr Ste 101, Sun City West, AZ 85375-5815 Ph: (623) 975-1660 |
News Archive
Varying practices and frequent lapses in nutrition delivery can put critically ill patients at greater risk for malnutrition and associated complications, according to an article in the August issue of Critical Care Nurse (CCN).
Two prominent microbiologists have launched a new peer-reviewed publication focusing on microbiome research in environmental, agricultural, and biomedical areas. Eric Wommack, from the University of Delaware's College of Earth, Ocean and Environment and Jacques Ravel, from the University of Maryland School of Medicine's Institute for Genome Sciences are the Editors-in-Chief of Microbiome, a BioMed Central (BMC) publication, which launched its first issue this week.
A new study led by researchers at Indiana University has found that women and older adults who use multiple prescription drugs are significantly more likely to be prescribed pills whose combination produces dangerous side effects.
Informed Medical Decisions, Inc. (InformedDNA) has been selected as one of 30 finalists for the Best Practices in Health Care Consumer Empowerment and Protection Awards. URAC, the nation's leading accreditation organization, will honor the finalists during their 11th Annual Quality Summit, October 5-7, 2010 in Chicago, IL.
Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping mutation had a 46.5% objective response rate to the targeted therapy drug tepotinib, as shown in a study published today in the New England Journal of Medicine and presented at the 2020 American Society of Clinical Oncology Annual Meeting ASCO20 Virtual Meeting (Abstract 9556 - Poster 322) by researchers from The University of Texas MD Anderson Cancer Center.
› Verified 7 days ago